SGC Open Notebookers support DIPG drug discovery by sharing their research on ALK2 in real-time

In January 2018, a group of post-doctoral fellows at the Structural Genomics Consortium (SGC) undertook the bold task of sharing their real-time and unpolished experimental results through open lab notebooks online in a mission to facilitate collaboration and transparency and to reduce duplication of effort.

Three of the Open Notebookers work on ACVR1/ALK2, the mutated target in a subset of DIPG patients. Drs. Roslin Adamson, Jong Fu Wong and Elizabeth Brown are based at Oxford University in the UK and are supervised by Dr. Alex Bullock.

You can read their latest blog post on ALK2 here:

By | 2018-05-09T10:56:22+00:00 March 15th, 2018|